Skip to content

BMRNBIOMARIN PHARMACEUTICAL INC

CUSIP 09061G101 · common stock · Other share classes: 09061GAK7

8 tracked investors held BIOMARIN PHARMACEUTICAL INC (BMRN) at the end of Q3 2026, worth $2.2B in total. The largest holder was PRIMECAP Management, with 0.6% of its portfolio. Lee Ainslie opened a new position this quarter.

Holders · Q3 2026
8
New holders
1
Value held
$2.2B
Quarter-end price (est.)
$60.00

Investors holding BMRN · Q3 2026

InvestorWeightSharesValueChange
PRIMECAP Management
PRIMECAP Management Co
0.56%14,988,996$899.3MADD+5.6%
Dodge & Cox
Dodge & Cox
0.47%14,625,740$877.5MREDUCE-1.5%
Andreas Halvorsen
Viking Global Investors LP
1.32%7,173,173$430.4MREDUCE-5.8%
Torray Funds
Torray Investment Partners LLC
0.58%73,615$4.4MREDUCE-5.3%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.13%51,200$3.1MADD+4.5%
Joel Greenblatt
Gotham Asset Management, LLC
0.00%25,474$1.5MREDUCE-11.1%
Mario Gabelli
GAMCO Investors, Inc.
0.00%6,000$360KREDUCE-53.8%
Lee Ainslie
Maverick Capital Ltd
0.00%4,088$245.3KNEW

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Ken Fisher0.00%35,389$2MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026811$2.2B$60.00
Q2 2026800$2.1B$57.22
Q1 2026810$2B$56.49
Q4 2025700$2.1B$59.43